Correlation Between Neuropace and Bruker
Can any of the company-specific risk be diversified away by investing in both Neuropace and Bruker at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Bruker into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and Bruker, you can compare the effects of market volatilities on Neuropace and Bruker and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Bruker. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Bruker.
Diversification Opportunities for Neuropace and Bruker
Modest diversification
The 3 months correlation between Neuropace and Bruker is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Bruker in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bruker and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Bruker. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bruker has no effect on the direction of Neuropace i.e., Neuropace and Bruker go up and down completely randomly.
Pair Corralation between Neuropace and Bruker
Given the investment horizon of 90 days Neuropace is expected to generate 1.51 times more return on investment than Bruker. However, Neuropace is 1.51 times more volatile than Bruker. It trades about 0.06 of its potential returns per unit of risk. Bruker is currently generating about -0.19 per unit of risk. If you would invest 1,087 in Neuropace on December 30, 2024 and sell it today you would earn a total of 98.00 from holding Neuropace or generate 9.02% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Neuropace vs. Bruker
Performance |
Timeline |
Neuropace |
Bruker |
Neuropace and Bruker Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Neuropace and Bruker
The main advantage of trading using opposite Neuropace and Bruker positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Bruker can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bruker will offset losses from the drop in Bruker's long position.Neuropace vs. Electromed | Neuropace vs. Orthopediatrics Corp | Neuropace vs. SurModics | Neuropace vs. Paragon 28 |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |